PMID- 14734202 OWN - NLM STAT- MEDLINE DCOM- 20040908 LR - 20190706 IS - 0009-8981 (Print) IS - 0009-8981 (Linking) VI - 340 IP - 1-2 DP - 2004 Feb TI - Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. PG - 107-15 AB - BACKGROUND: Diabetics and experimental animal models exhibit high oxidative stress due to persistent and chronic hyperglycemia, thereby deplete the activity of the antioxidative defense system and thereby promote the generation of free radicals. The current study examined the effects of vitamin E on oxidative stress and membrane fluidity in the brain of diabetes-induced rats. METHODS: Sprague-Dawley male rats were randomly assigned to normal and streptozotocin (STZ)-induced diabetic groups. The diabetic groups were fed a vitamin E-free diet, 40 mg vitamin E/kg diet, or 400 mg vitamin E/kg diet. Diabetes was induced with STZ after 3 weeks of the experimental diet, then the rats were sacrificed 9 days later to determine the oxidative stress and cell membrane fluidity in the brain. RESULTS: Dietary vitamin E strengthened the antioxidative defense system with an increased activity of the antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) and increased vitamin E content, in the brain of the diabetes-induced experimental rats. Accordingly, vitamin E was found to reduce the accumulation of reactive oxygen species (ROS), such as superoxide radical decrease the generation of oxidative damage substances, such as the carbonyl value, increase the membrane fluidity lowered by oxidative damage, and significantly improve the lipid composition. CONCLUSIONS: Vitamin E was found to be excellent for strengthening the antioxidative defense system, reducing the generation of ROS and damaging oxidative substances, and maintaining membrane fluidity in the brain of diabetes-induced rats. FAU - Hong, Jung-Hee AU - Hong JH AD - Department of Food Science and Nutrition, Catholic University of Daegu, Gyeongsan-si, Gyeongbuk 712-702, South Korea. FAU - Kim, Mi-Ji AU - Kim MJ FAU - Park, Mo-Ra AU - Park MR FAU - Kwag, Oh-Gye AU - Kwag OG FAU - Lee, In-Seon AU - Lee IS FAU - Byun, Boo Hyeong AU - Byun BH FAU - Lee, Soo-Chun AU - Lee SC FAU - Lee, Kyung-Bok AU - Lee KB FAU - Rhee, Soon-Jae AU - Rhee SJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Clin Chim Acta JT - Clinica chimica acta; international journal of clinical chemistry JID - 1302422 RN - 0 (Antioxidants) RN - 0 (Phospholipids) RN - 0 (Reactive Oxygen Species) RN - 0 (Triglycerides) RN - 1406-18-4 (Vitamin E) RN - 5W494URQ81 (Streptozocin) RN - 97C5T2UQ7J (Cholesterol) SB - IM MH - Animals MH - Antioxidants/administration & dosage/*pharmacology MH - Brain/*drug effects/metabolism MH - Cholesterol/metabolism MH - Diabetes Mellitus, Experimental/chemically induced/*metabolism/*pathology MH - Male MH - Membrane Fluidity/*drug effects MH - Oxidative Stress/*drug effects/physiology MH - Phospholipids/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Reactive Oxygen Species/metabolism MH - Streptozocin/pharmacology MH - Triglycerides/metabolism MH - Vitamin E/administration & dosage/*pharmacology EDAT- 2004/01/22 05:00 MHDA- 2004/09/09 05:00 CRDT- 2004/01/22 05:00 PHST- 2004/01/22 05:00 [pubmed] PHST- 2004/09/09 05:00 [medline] PHST- 2004/01/22 05:00 [entrez] AID - S0009898103004601 [pii] AID - 10.1016/j.cccn.2003.10.003 [doi] PST - ppublish SO - Clin Chim Acta. 2004 Feb;340(1-2):107-15. doi: 10.1016/j.cccn.2003.10.003.